International GPCR Consortium Includes China Academic Members

The GPCR Consortium, a new not-for-profit effort, will seek to characterize the structure of 200 G-protein coupled receptors. Although GPCRs often serve as drug targets, they remain poorly understood, especially in terms of their structure. The Consortium, spearheaded by Dr. Raymond Stevens, a structural biologist and serial entrepreneur, includes two China institutions -- the iHuman Institute at ShanghaiTech University and the Shanghai Institute of Materia Medica -- along with the University of Southern California, Amgen, Sanofi and Ono. All of the Consortium's findings will be placed in the public domain.

Help employers find you! Check out all the jobs and post your resume.